Replication in cells of hematopoietic origin is necessary for dengue virus dissemination

PLoS Pathogens

Volumn 8, Issue 1, 2012, Pages

  Pham, Alissa M ^a   Langlois, Ryan A ^a   tenOever, Benjamin R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; GLYCOPROTEIN P 15095; MICRORNA;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DENGUE VIRUS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; VIRAL TROPISM; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD; DENGUE; DENGUE VIRUS; HEK293 CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, KNOCKOUT; MICRORNAS; VIRUS REPLICATION;

DENGUE VIRUS;

EID: 84857477803     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002465     Document Type: Article

References (53)

1. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, et al. (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8: S7-S16.
2. (2002) DengueNet-WHO's Internet-based System for the global surveillance of dengue fever and dengue haemorrhagic fever (dengue/DHF) http://www.who.int/denguenet. Dengue/DHF-global public health burden. Wkly Epidemiol Rec 77: 300-304.
3. Clyde K, Kyle JL, Harris E, (2006) Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 80: 11418-11431.
4. Chambers TJ, Hahn CS, Galler R, Rice CM, (1990) Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44: 649-688.
5. Halstead SB, O'Rourke EJ, (1977) Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 146: 201-217.
6. Goncalvez AP, Engle RE, St Claire M, Purcell RH, Lai CJ, (2007) Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci U S A 104: 9422-9427.
7. Rigau-Perez JG, (2006) Severe dengue: the need for new case definitions. Lancet Infect Dis 6: 297-302.
8. Halstead SB, O'Rourke EJ, (1977) Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265: 739-741.
9. Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, et al. (2000) Human skin Langerhans cells are targets of dengue virus infection. Nat Med 6: 816-820.
10. Luplertlop N, Surasombatpattana P, Patramool S, Dumas E, Wasinpiyamongkol L, et al. (2011) Induction of a peptide with activity against a broad spectrum of pathogens in the Aedes aegypti salivary gland, following Infection with Dengue Virus. PLoS Pathog 7: e1001252.
11. Blackley S, Kou Z, Chen H, Quinn M, Rose RC, et al. (2007) Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J Virol 81: 13325-13334.
12. Rodenhuis-Zybert IA, Wilschut J, Smit JM, (2010) Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci 67: 2773-2786.
13. Chen YC, Wang SY, King CC, (1999) Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J Virol 73: 2650-2657.
14. Reyes-Del Valle J, Chavez-Salinas S, Medina F, Del Angel RM, (2005) Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol 79: 4557-4567.
15. Mercado-Curiel RF, Black WCt, Munoz Mde L, (2008) A dengue receptor as possible genetic marker of vector competence in Aedes aegypti. BMC Microbiol 8: 118.
16. Miller JL, de Wet BJ, Martinez-Pomares L, Radcliffe CM, Dwek RA, et al. (2008) The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog 4: e17.
17. Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, et al. (1997) Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3: 866-871.
18. Dalrymple N, Mackow ER, (2011) Productive Dengue Virus Infection of Human Endothelial Cells is Directed By Heparan Sulfate-Containing Proteoglycan Receptors. J Virol 85: 9478-9485.
19. Zellweger RM, Prestwood TR, Shresta S, (2010) Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7: 128-139.
20. Balsitis SJ, Coloma J, Castro G, Alava A, Flores D, et al. (2009) Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg 80: 416-424.
21. Jessie K, Fong MY, Devi S, Lam SK, Wong KT, (2004) Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 189: 1411-1418.
22. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
23. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
24. Lai EC, (2002) Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 30: 363-364.
25. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
26. Shin C, Nam JW, Farh KK, Chiang HR, Shkumatava A, et al. (2010) Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell 38: 789-802.
27. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, et al. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
28. Yigit E, Batista PJ, Bei Y, Pang KM, Chen CC, et al. (2006) Analysis of the C. elegans Argonaute family reveals that distinct Argonautes act sequentially during RNAi. Cell 127: 747-757.
29. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, et al. (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science 305: 1437-1441.
30. Parker JS, Roe SM, Barford D, (2005) Structural insights into mRNA recognition from a PIWI domain-siRNA guide complex. Nature 434: 663-666.
31. Perez JT, Pham AM, Lorini MH, Chua MA, Steel J, et al. (2009) MicroRNA-mediated species-specific attenuation of influenza A virus. Nat Biotechnol 27: 572-576.
32. Barnes D, Kunitomi M, Vignuzzi M, Saksela K, Andino R, (2008) Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 4: 239-248.
33. Kelly EJ, Nace R, Barber GN, Russell SJ, (2010) Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. J Virol 84: 1550-1562.
34. Kelly EJ, Hadac EM, Greiner S, Russell SJ, (2008) Engineering microRNA responsiveness to decrease virus pathogenicity. Nat Med 14: 1278-1283.
35. Leber MF, Bossow S, Leonard VH, Zaoui K, Grossardt C, et al. MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector Tropism. Mol Ther 19: 1097-1106.
36. Edge RE, Falls TJ, Brown CW, Lichty BD, Atkins H, et al. (2008) A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication. Mol Ther 16: 1437-1443.
37. Heiss BL, Maximova OA, Pletnev AG, (2011) Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype. J Virol 85: 1464-1472.
38. Gitlin L, Stone JK, Andino R, (2005) Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J Virol 79: 1027-1035.
39. Leber MF, Bossow S, Leonard VH, Zaoui K, Grossardt C, et al. (2011) MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector Tropism. Mol Ther 19: 1097-1106.
40. Lee TC, Lin YL, Liao JT, Su CM, Lin CC, et al. (2010) Utilizing liver-specific microRNA-122 to modulate replication of dengue virus replicon. Biochem Biophys Res Commun 396: 596-601.
41. Rodriguez-Madoz JR, Bernal-Rubio D, Kaminski D, Boyd K, Fernandez-Sesma A, (2010) Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol 84: 4845-4850.
42. Rodriguez-Madoz JR, Belicha-Villanueva A, Bernal-Rubio D, Ashour J, Ayllon J, et al. (2010) Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J Virol 84: 9760-9774.
43. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
44. Brown BD, Venneri MA, Zingale A, Sergi Sergi L, Naldini L, (2006) Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat Med 12: 585-591.
45. Lodeiro MF, Filomatori CV, Gamarnik AV, (2009) Structural and functional studies of the promoter element for dengue virus RNA replication. J Virol 83: 993-1008.
46. Alvarez DE, De Lella Ezcurra AL, Fucito S, Gamarnik AV, (2005) Role of RNA structures present at the 3′UTR of dengue virus on translation, RNA synthesis, and viral replication. Virology 339: 200-212.
47. Wang Y, Sheng G, Juranek S, Tuschl T, Patel DJ, (2008) Structure of the guide-strand-containing argonaute silencing complex. Nature 456: 209-213.
48. Mordstein M, Neugebauer E, Ditt V, Jessen B, Rieger T, et al. (2008) Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol 84: 5670-5677.
49. Williams KL, Zompi S, Beatty PR, Harris E, (2009) A mouse model for studying dengue virus pathogenesis and immune response. Ann N Y Acad Sci 1171 (Suppl 1): E12-23.
50. Brown BD, Cantore A, Annoni A, Sergi LS, Lombardo A, et al. (2007) A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood 110: 4144-4152.
51. Alvarez DE, Lodeiro MF, Luduena SJ, Pietrasanta LI, Gamarnik AV, (2005) Long-range RNA-RNA interactions circularize the dengue virus genome. J Virol 79: 6631-6643.
52. Kinney RM, Butrapet S, Chang GJ, Tsuchiya KR, Roehrig JT, et al. (1997) Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230: 300-308.
53. Varble A, Chua MA, Perez JT, Manicassamy B, Garcia-Sastre A, et al. (2010) Engineered RNA viral synthesis of microRNAs. Proc Natl Acad Sci U S A 107: 11519-11524.